Is there a real standard for stage IVa cervical cancer?

Gynecologic Oncology

Volumn 123, Issue 1, 2011, Pages 174-175

  Bellati, Filippo ^a   Gasparri, Maria Luisa ^a   Benedetti Panici, Pierluigi ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RADIOTHERAPY; CANCER SURVIVAL; CHEMORADIOTHERAPY; CHRONIC KIDNEY FAILURE; DEHYDRATION; DISEASE SEVERITY; FEMALE; GOLD STANDARD; HUMAN; LETTER; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; SURVIVAL TIME; TREATMENT RESPONSE; TUMOR VOLUME; UTERINE CERVIX CANCER; VAGINA DISEASE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; HUMANS; UTERINE CERVICAL NEOPLASMS;

EID: 80052560749     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2011.05.015     Document Type: Letter

References (9)

1. P.G. Rose, S. Ali, C.W. Whitney, R. Lanciano, and F.B. Stehman Outcome of stage IVA cervical cancer patients with disease limited to the pelvis in the era of chemoradiation: A Gynecologic Oncology Group study Gynecol Oncol 121 2011 542 545
2. M.A. Quinn, J.L. Benedet, F. Odicino, P. Maisonneuve, U. Beller, W.T. Creasman, A.P. Heintz, H.Y. Ngan, and S. Pecorelli Carcinoma of the cervix uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer Int J Gynaecol Obstet 95 1 Suppl 1 2006 S43 S103
3. C.A. Perez, P.W. Grigsby, K.S. Chao, D.G. Mutch, and M.A. Lockett Tumor size, irradiation dose, and long-term outcome of carcinoma of uterine cervix Int J Radiat Oncol Biol Phys 41 1998 307 317 (Pubitemid 28243542)
4. P. Benedetti Panici, F. Bellati, M. Pastore, N. Manci, A. Musella, S. Pauselli, M. Angelucci, L. Muzii, and R. Angioli An update in neoadjuvant chemotherapy in cervical cancer Gynecol Oncol 107 1 Suppl 1 2007 S20 S22
5. P. Benedetti Panici, F. Bellati, N. Manci, M. Pernice, F. Plotti, V. Di Donato, M. Calcagno, M.A. Zullo, L. Muzii, and R. Angioli Neoadjuvant chemotherapy followed by radical surgery in patients affected by FIGO stage IVA cervical cancer Ann Surg Oncol 14 2007 2643 2648 (Pubitemid 47389564)
6. R. Angioli, M.A. Zullo, F. Plotti, F. Bellati, S. Basile, P. Damiani, G. Perniola, M. Calcagno, and P.B. Panici Urologic function and urodynamic evaluation of urinary diversion (Rome pouch) over time in gynecologic cancers patients Gynecol Oncol 107 2007 200 204 (Pubitemid 47575731)
7. A. Buda, R. Fossati, N. Colombo, F. Fei, I. Floriani, D. Gueli Alletti, D. Katsaros, F. Landoni, A. Lissoni, C. Malzoni, E. Sartori, P. Scollo, V. Torri, P. Zola, and C. Mangioni Randomized trial of neoadjuvant chemotherapy comparing paclitaxel, ifosfamide, and cisplatin with ifosfamide and cisplatin followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the SNAP01 (Studio Neo-Adjuvante Portio) Italian Collaborative Study J Clin Oncol 23 2005 4137 4145 (Pubitemid 46211319)
8. P. Benedetti Panici, N. Manci, F. Bellati, V. Di Donato, C. Marchetti, C. De Falco, C. Di Tucci, and R. Angioli Vaginectomy: a minimally invasive treatment for cervical cancer vaginal recurrence Int J Gynecol Cancer 19 2009 1625 1631
9. R. Angioli, M. Penalver, L. Muzii, L. Mendez, R. Mirhashemi, F. Bellati, C. Croce, and P.B. Panici Guidelines of how to manage vesicovaginal fistula Crit Rev Oncol Hematol 48 2003 295 304 (Pubitemid 38018972)